Aduhelm (Drug) – Page 2

Alzheimer’s Drug Slows Cognitive Decline in Key Study

Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.

Social Security’s Cost-of-Living Increase Will Be Largest in Four Decades, an Estimate Says

Retirees will learn the amount of the increase for 2023 in October, and the current estimate is that it will be 8.7%.

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.

Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug

The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.

F.D.A.’s Accelerated Drug Approvals Come Under Scrutiny

A drug to prevent preterm birth may provide the next test of the agency’s process for speedily getting drugs on the market, despite limited evidence that some work.